Compounds > desacetylnantradol
Page last updated: 2024-09-03

desacetylnantradol and dronabinol

desacetylnantradol has been researched along with dronabinol in 5 studies

Compound Research Comparison

Studies
(desacetylnantradol)		Trials
(desacetylnantradol)		Recent Studies (post-2010)
(desacetylnantradol)		Studies
(dronabinol)		Trials
(dronabinol)		Recent Studies (post-2010) (dronabinol)
18008,3077853,094

Protein Interaction Comparison

ProteinTaxonomydesacetylnantradol (IC50)dronabinol (IC50)
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.218
Cannabinoid receptor 1Homo sapiens (human)0.0028
Cannabinoid receptor 2 Homo sapiens (human)0.0095
Cannabinoid receptor 2Rattus norvegicus (Norway rat)0.218

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, SF; Howlett, AC; Paule, MG; Scallet, AC; Slikker, W; Westlake, TM1
Bidaut-Russell, M; Howlett, AC1
Howlett, AC2
Howlett, AC; Ruh, MF; Taylor, JA; Welshons, WV1

Other Studies

5 other study(ies) available for desacetylnantradol and dronabinol

ArticleYear
Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors.
    Brain research, 1991, Mar-22, Volume: 544, Issue:1

    Topics: Analgesics; Animals; Brain; Cannabinoids; Cerebellum; Cerebral Cortex; Cyclohexanols; Dronabinol; Hippocampus; Kinetics; Macaca mulatta; Male; Organ Specificity; Phenanthridines; Rats; Rats, Inbred Strains; Receptors, Cannabinoid; Receptors, Drug

1991
Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum.
    Journal of neurochemistry, 1991, Volume: 57, Issue:5

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics; Animals; Corpus Striatum; Cyclic AMP; Dopamine Agents; Dronabinol; Ergolines; In Vitro Techniques; Kinetics; Male; Morphine; Naloxone; Phenanthridines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Cannabinoid; Receptors, Drug; Vasoactive Intestinal Peptide

1991
Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.
    Molecular pharmacology, 1985, Volume: 27, Issue:4

    Topics: Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Animals; Cannabinoids; Cell Line; Cell Membrane; Chlorides; Dronabinol; Guanosine Triphosphate; Kinetics; Magnesium; Magnesium Chloride; Manganese; Manganese Compounds; Mice; Neuroblastoma; Phenanthridines; Secretin; Substrate Specificity

1985
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.
    Life sciences, 1984, Oct-22, Volume: 35, Issue:17

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Alprostadil; Animals; Carbachol; Cell Line; Cyclic AMP; Dronabinol; Epoprostenol; Guanylyl Imidodiphosphate; Neuroblastoma; Phenanthridines; Phosphodiesterase Inhibitors; Prostaglandins E; Secretin; Sodium Fluoride

1984
Failure of cannabinoid compounds to stimulate estrogen receptors.
    Biochemical pharmacology, 1997, Jan-10, Volume: 53, Issue:1

    Topics: Breast Neoplasms; Cannabinoids; Cell Division; Dronabinol; Estrogens; Humans; Phenanthridines; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Transcriptional Activation; Tumor Cells, Cultured

1997